Cross Country Healthcare Inc

The stock is in a Stage 2 advancing phase under a strong parabola-driven rally, consolidating tightly above the rising 9/20 EMAs and the 200 DMA after a steep advance. However, overextension above EMAs and an elevated RSI warn against chasing current highs. Without a Lockout Rally override and given the pattern's vulnerability to abrupt reversal, execution should be deferred until shallow pullbacks into the rising EMAs offer a better entry opportunity.

• ↑Orders +20% since Q2 start indicates stabilizing demand across specialties
• ↑Q4 2025 cash $109M, zero debt provides M&A and buyback flexibility
• ↓Travel nurse & allied revenue down 48% YoY strains top-line growth